Home / Investors Information / EDAP Reports Installation of Ablatherm Robotic HIFU at University of Southern California Read more about EDAP Reports Installation of Ablatherm Robotic HIFU at University of Southern California Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress Read more about Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress EDAP Reports Third Quarter 2015 Financial Results and Operational Update Read more about EDAP Reports Third Quarter 2015 Financial Results and Operational Update EDAP to Hold Third Quarter 2015 Conference Call on November 19, 2015 Read more about EDAP to Hold Third Quarter 2015 Conference Call on November 19, 2015 EDAP Records First Three U.S. Orders for Ablatherm HIFU Read more about EDAP Records First Three U.S. Orders for Ablatherm HIFU EDAP Announces Dismissal of Class Action Lawsuit Read more about EDAP Announces Dismissal of Class Action Lawsuit EDAP Announces Focal One(R) HIFU Sale to Clinica Santa Maria de Santiago de Chile Read more about EDAP Announces Focal One(R) HIFU Sale to Clinica Santa Maria de Santiago de Chile EDAP Receives FDA Approval for Ablatherm HIFU Read more about EDAP Receives FDA Approval for Ablatherm HIFU EDAP Reports on Recent, Active Urology Congress and Clinical Activity Read more about EDAP Reports on Recent, Active Urology Congress and Clinical Activity EDAP Direct De Novo for Ablatherm HIFU Replaced by 510(k) Read more about EDAP Direct De Novo for Ablatherm HIFU Replaced by 510(k) Pagination First page « First Previous page ‹ Previous … Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Page 27 Page 28 … Next page Next › Last page Last » Subscribe to
EDAP Reports Installation of Ablatherm Robotic HIFU at University of Southern California Read more about EDAP Reports Installation of Ablatherm Robotic HIFU at University of Southern California
Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress Read more about Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress
EDAP Reports Third Quarter 2015 Financial Results and Operational Update Read more about EDAP Reports Third Quarter 2015 Financial Results and Operational Update
EDAP to Hold Third Quarter 2015 Conference Call on November 19, 2015 Read more about EDAP to Hold Third Quarter 2015 Conference Call on November 19, 2015
EDAP Records First Three U.S. Orders for Ablatherm HIFU Read more about EDAP Records First Three U.S. Orders for Ablatherm HIFU
EDAP Announces Dismissal of Class Action Lawsuit Read more about EDAP Announces Dismissal of Class Action Lawsuit
EDAP Announces Focal One(R) HIFU Sale to Clinica Santa Maria de Santiago de Chile Read more about EDAP Announces Focal One(R) HIFU Sale to Clinica Santa Maria de Santiago de Chile
EDAP Receives FDA Approval for Ablatherm HIFU Read more about EDAP Receives FDA Approval for Ablatherm HIFU
EDAP Reports on Recent, Active Urology Congress and Clinical Activity Read more about EDAP Reports on Recent, Active Urology Congress and Clinical Activity
EDAP Direct De Novo for Ablatherm HIFU Replaced by 510(k) Read more about EDAP Direct De Novo for Ablatherm HIFU Replaced by 510(k)
